These results showed that STAT3 inhibition effectively mitigated inflammation by retrieving the CD11blowF4/80high population, suggesting the therapeutic potential of STAT3 inhibitor in alleviating kidney injury in the L-AKI model. The gene discussed is STAT3; the disease is injury.